Med. praxi. 2025;22(2):119-122 | DOI: 10.36290/med.2025.028

The role of D­‑mannose in the treatment of infections of the urinary tract

MUDr. Eva Burešová, Ph.D.
Urologická klinika LF UP a FN Olomouc

Urinary tract infections are common, especially in women. It is a bacterial inflammation, therefore antibiotics are the drug of choice. Long-term prophylaxis with low doses of these agents is recommended for the prevention of recurrent IMC. When taking antibiotics, patients may be bothered by side effects and, in addition, the risk of increasing bacterial resistance increases. As part of non-antibiotic prophylaxis, intravesical instillation of hyaluronic acid or peroral preparations acting against bacteria directly in the bladder, including D-mannose, is recommended.

Keywords: urinary tract infection, antibiotic therapy, D­‑mannose, recurrent infection, IMC prophylaxis.

Received: February 17, 2025; Revised: April 11, 2025; Accepted: April 14, 2025; Published: April 30, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Burešová E. The role of D­‑mannose in the treatment of infections of the urinary tract. Med. praxi. 2025;22(2):119-122. doi: 10.36290/med.2025.028.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 30.4.2026

    References

    1. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin N Am. 2014;28(1):1-13. Go to original source... Go to PubMed...
    2. Sewify M, Nair S, Warsame S, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled Glycemia in Kuwait. J Diabetes Res. 2016;2016:6573215. Go to original source... Go to PubMed...
    3. FloresMireles AL, Walker JN, Caparon M, et al. Urinary tract infec tions: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. Go to original source... Go to PubMed...
    4. Loubet P, Ranfaing J, Dinh A, et al. Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol. 2020;11:1509. Go to original source... Go to PubMed...
    5. Mestrovic T, Matijasic M, Peric M, et al. The role of gut, vaginal, and urinary microbiome in urinary tract infec tions: from bench to bedside. Diagnostics (Basel). 2021;11:7. Go to original source... Go to PubMed...
    6. European Association of Urology (EAU) Guidelines on Urological infection. 2024. Available from: uroweb.org.
    7. Hickling DR, Nitti VW. Management of reccurrent urinary tract infection in healthy adult women. Rev Urol. 2013;15(2):41-48.
    8. Nickel JC. Practical management of recurrent urinary tract infection in premanopausal women. Rev Urol. 2005;7:11-17.
    9. Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infection in women. World J R Urol. 1999;17:415-420. Go to original source... Go to PubMed...
    10. Alton G, Hasilik M, Niehues R, et al. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 2001;8:285-295. Go to original source... Go to PubMed...
    11. Hu X, Shi Y, Zhang P, et al. D mannose properties, production and applicantions. An overview. Compr Rec Food Sci Food Saf. 2016;15:773-785. Go to original source... Go to PubMed...
    12. Aidelberg G, Towbin BD, Rothschild D, et al. Hierarchy of non­‑glucose sugars in escherichia coli. BMC syst Biol. 2014;8:133. Go to original source... Go to PubMed...
    13. Sarshar M, Behzadi P, Ambrosi C, et al. FimH nd antiadhesive therapeutics: A disaring strategy against uropatogens. Antibiotics (Basel). 2020;9:397. Go to original source... Go to PubMed...
    14. Yamabhai M, SakUbol S, Srila W, et al. Mannan biotechnology: from biofuels to health. Crit Rev Biotechnol. 2016;36(1):32-42. Go to original source... Go to PubMed...
    15. Sharma V, Smolin J, Nayak J, et al. Mannose alters gut microbiome, prevents dietinduced obesity, and improves host metabolism. Cell Rep. 2018;24(12):3087-98. Go to original source... Go to PubMed...
    16. Bouckaert J, Berglund J, Schembri M, et al. Receptor binding studies disclose a novel class of high affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol. 2005;55(2):441-55. Go to original source... Go to PubMed...
    17. Toyota S, Fukushi Y, Katoh S, et al. Antibacterial defense mechanism of the urinary bladder. Role of mannose in urine. Nihon Hinyokika Gakkai Zasshi. 1989;80(12):1816-23. Go to original source... Go to PubMed...
    18. Jones CH, Pinkner JS, Roth R et al. FimH adhezin of type 1 pili is assembler into a fibrilar tip structure in Enterobariaceae. Proct Nati Acad Sci USA. 1995;92:2081-5. Go to original source... Go to PubMed...
    19. Zhang D, Chia C, Jiao X, et al. Dmannose induces regulatory T cells and suppresses immunopathology. Nat Med. 2017;23(9):1036-45. Go to original source... Go to PubMed...
    20. Lenger S, Bradley MS, Thomas DA, et al. D­‑mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta­‑analysis. Am J Obstet Gynecol. 2020;223(2):265-13. Go to original source... Go to PubMed...
    21. Ala­‑Jaakola R, Laitila A, Ouwehand AC, et al. Role of D­‑mannose in urinary tract infections - a narrative review. Nutr J. 2022;21:18. Go to original source... Go to PubMed...
    22. Sharma V, Nayak J, DeRossi C, et al. Man nose supplements induce embryonic lethality and blindness in phospho mannose isomerase hypomorphic mice. FASEB J. 2014;28(4):1854-69. Go to original source... Go to PubMed...
    23. Porru D, Pirmigiani A, Tinelli C, et al. Oral D­‑mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology. 2014;7(3):208-213. Go to original source...
    24. Panchev P, Slavov C, Mladenov D, et al. A multicenter comparative observation on the effectiveness and the rapid ness of the effect of Cystostop rapid versus antibiotic therapy in patients with uncomplicated cystitis. Akush Ginekol (Sofiia). 2012;51(7):49-55.
    25. Domenici L, Monti M, Bracchi C, et al. D­‑mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920-2925. https://uriroyal.rs/kako­‑deluje­‑d-manoza/.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.